360 Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

360 Financial’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.7M	Buy	78,213 +6,128	+9%	+$1.27M	4.73%	7
2025 Q4	$14.9M	Buy	+72,085	New	+$14.4M	4.5%	7
2020 Q3	–	Sell	-32,342	Closed	-$5.59M	–	72
2020 Q2	$5.59M	Buy	+32,342	New	+$5.08M	4.64%	7

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

360 Financial's FBT Position: Q1 2026 in Review

360 Financial increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 8.5% in Q1 2026, buying an estimated $1.27M and bringing the position to 78,213 shares worth $15.7M. The position accounts for 4.73% of the portfolio, ranked #7.

360 Financial first reported a position in FBT in Q2 2020 and has held it in 3 quarters since. 308 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

360 Financial held 78,213 shares of First Trust NYSE Arca Biotechnology Index Fund worth $15.7M as of Q1 2026.
360 Financial bought 6,128 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $1.27M.
First Trust NYSE Arca Biotechnology Index Fund made up 4.73% of 360 Financial's portfolio in Q1 2026, its #7 holding.
360 Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 3 quarters since.
308 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on 360 Financial's 13F filing for Q1 2026, filed 7 May 2026.